Cardiovascular Institute

Stanford Cardiovascular Institute Completes
Strategic Planning Process; Develops Five-Year Plan

In 2008, Institute members began work on a strategic plan. To be released in Spring 2010, the plan will provide a blueprint for building a comprehensive enterprise for Stanford cardiovascular research and training.

cardiac stem cells
Cardiac stem cells

At Stanford University, we are determined to discover why, despite countless advances in cardiovascular medicine, hearts continue to fail. Ultimately, we want to prevent and cure cardiovascular disease.  It's a lofty and urgent vision for the future, considering that each year, more than 17 million people worldwide die of cardiovascular diseases. We believe that by tapping the optimism and creative energy that have characterized Stanford since its founding, we can deliver new ways to prevent, detect, treat, and eventually cure these challenging diseases.

Nearly 50 years ago, Stanford defined the cardiovascular frontier in the United States by performing the country's first open-heart operation. Stanford continued making medical history with the nation's first adult heart transplant and therapeutic balloon angioplasty, and then the world's first successful combined heart-lung transplant.  Today, Stanford's cardiovascular scientists persist in extending the boundaries of what is known about the prevention and treatment of heart disease.

The Stanford Cardiovascular Institute (CVI) is the nexus for Stanford's battle against heart disease. As one of the most comprehensive heart centers in the country, the institute unites all cardiovascular-related adult and pediatric research, patient care, and education programs and centers. The institute has one mission: lifting the burden of cardiovascular disease in our lifetime and for future generations.

Strategic Plan [coming in Fall, 2009]

Stanford Medicine Resources:

Footer Links: